Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Research

Medicine bar code

Substandard and falsified medicines: global and local efforts to address a growing problemSubscription

By

Substandard and falsified medicines pose a risk to public health all around the world.

Insight

young and old hand with blood sugar test tubes

‘One-size-fits-all’ treatment targets harm frail older patients with diabetesSubscription

By ,

HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.

CPD article

Early lesions from Stevens–Johnson syndrome

Stevens–Johnson syndrome and toxic epidermal necrolysisSubscription

By , , , , , ,

Practical guidelines for the treatment and management of Stevens–Johnson syndrome and toxic epidermal necrolysis, rare but life-threatening conditions that are normally caused by drugs or infections.

Research briefing

Colon cancer micrograph

Triple-combination therapy prevents drug resistance in colorectal cancer cellsSubscription

7 MAY 2019

Treating colorectal cancer with a trio of targeted drugs reduces the acquisition of drug resistance, in vitro research published in Oncogene shows.

busy hospital waiting room

Depression under-recognised in older adults during acute hospital staysSubscription

18 APR 2019

Diagnosis of depression is infrequently recorded on older adults’ patient notes, a survey of 27 acute hospitals across England has shown.

Older person's bedside with medicines

Sleeping tablets linked to increased antihypertensive useSubscription

17 APR 2019

Older adults with hypertension who take sleeping tablets are more likely to receive an increased number of antihypertensive medicines over time, study results have shown.

Pregnant woman taking a tablet

Painkiller link to childhood asthma unlikely to be causal, researchers saySubscription

15 APR 2019

A previously reported association between analgesic use in pregnancy and childhood asthma is likely to result from confounding factors, researchers have concluded.

Short communications

Piloting an undergraduate student-led health check serviceSubscription

There is a growing focus on the development of communication and clinical skills during undergraduate pharmacy programmes; this has been demonstrated particularly by the General Pharmaceutical Council’s recent consultation on initial education and training

Reducing cephalosporin-related supply errorsSubscription

Cephalosporins are a class of beta-lactam antimicrobials that exert bactericidal effects through disruption of the bacterial cell wall. These broad-spectrum antimicrobials have played a core role in the treatment of severe infections since their launch in the latter half of the 20th century. Early generation cephalosporins provide robust coverage of Gram-positive bacteria, while the newer third- and fourth-generations offer additional Gram-negative coverage, including Pseudomonas ...

Clinical Pharmacist

Cover cp 11 05 19

CP May 2019, Vol 11, No 5

Cover Story:

Limiting substandard and falsified medicines

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.